A Comparison Between Lidocaine and nalbuphine on the Prevention of propofol Injection pain during gastroscopy

A Comparison Between Lidocaine and nalbuphine on the Prevention of propofol injection pain during gastroscopy

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900025438

Enrollment

Unknown

Registered

2019-08-26

Start date

2019-09-01

Completion date

Unknown

Last updated

2019-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

injection pain

Interventions

Group C: Saline

nalbuphine group:Nalbuphine

Lidocaine group:Lidocaine

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. aged 18–70 years; 2. an American Society of Anesthesiologists (ASA) physical status classification of I–II; 3. scheduled for gastroscopy.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of renal or hepatic insufficiency; 2. hypersensitivity to the study drugs; 3. neurological or cardiovascular disease and patients with obesity; 4. difficult airway; 5. pregnant patients; 6. patients on medication with pain modifying drugs.

Design outcomes

Primary

Measure	Time frame
pain;	—

Secondary

Measure	Time frame
intensity of pain;	—

Countries

China

Contacts

Public ContactLu Yao

The First Affiliated Hospital of Anhui Medical University

luyao-mz@163.com+86 18956564060

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 17, 2026